The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

Enhertu isn’t a typical chemotherapy or immunotherapy drug but rather a combination of chemotherapy and targeted therapy, known as an antibody-drug conjugate. Enhertu works by using an antibody to ...

Researchers discovered that treating pancreatic cancer with a common chemotherapy drug makes immunotherapy more effective. Folinic acid elevates levels of two anti-cancer immune molecules within ...

OHSU researchers found that combining venetoclax with breast cancer drug palbociclib strongly improves AML treatment by ...

The chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as both heat-seeking missiles and Trojan horses for cancer cells, designed to specifically home in on a ...

Doxorubicin is a type of anthracycline chemotherapy drug used to treat certain types of solid tumors and blood cancers. It has a number of side effects, some more serious than others. Experts predict ...

An early-stage study has found that a common chemotherapy drug disrupts lymphatic cells in the tissue surrounding the brain. This is linked to memory issues in mice. When you purchase through links on ...

Immunotherapy and targeted therapy — including PARP inhibitors and antibody-drug conjugates — can all be effective next steps for fighting breast cancer. Even though chemotherapy is the standard ...